76 related articles for article (PubMed ID: 8350621)
1. Dynamics of interaction between DNA-specific antitumor agents and serum-contained cytokines in the initiation of ML-1 human myeloblastic leukemia cell differentiation.
Bloch A
Leukemia; 1993 Aug; 7(8):1219-24. PubMed ID: 8350621
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of interaction between antineoplastic agents and natural differentiation factors in the induction of human leukemic cell maturation.
Honma Y; Honma C; Bloch A
Cancer Res; 1986 Dec; 46(12 Pt 1):6311-5. PubMed ID: 3465437
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3.
Hu ZB; Ma W; Zaborski M; MacLeod R; Quentmeier H; Drexler HG
Leukemia; 1996 Jun; 10(6):1025-40. PubMed ID: 8667638
[TBL] [Abstract][Full Text] [Related]
4. Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase.
Yamamoto-Yamaguchi Y; Makishima M; Kanatani Y; Kasukabe T; Honma Y
Exp Hematol; 1996 May; 24(6):682-9. PubMed ID: 8635523
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha, transforming growth factor-beta, and tetradecanoylphorbol acetate: competence factors for ML-1 human myeloblastic leukemia cell differentiation.
Guan XP; Hromchak RA; Takuma T; Denstman SC; Bloch A
Cancer Commun; 1991 Jan; 3(1):11-4. PubMed ID: 1989643
[TBL] [Abstract][Full Text] [Related]
6. Macromolecular and cell cycle effects of different classes of agents inducing the maturation of human myeloblastic leukemia (ML-1) cells.
Craig RW; Frankfurt OS; Sakagami H; Takeda K; Bloch A
Cancer Res; 1984 Jun; 44(6):2421-9. PubMed ID: 6586286
[TBL] [Abstract][Full Text] [Related]
7. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
8. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
9. Effects of transforming growth factor beta, tumor necrosis factor alpha, interferon gamma and LIF-HILDA on the proliferation of acute myeloid leukemia cells.
Kerangueven F; Sempere C; Tabilio A; Mannoni P
Eur Cytokine Netw; 1990; 1(2):99-107. PubMed ID: 2129395
[TBL] [Abstract][Full Text] [Related]
10. Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs.
Tafuri A; Lemoli RM; Chen R; Gulati SC; Clarkson BD; Andreeff M
Leukemia; 1994 May; 8(5):749-57. PubMed ID: 7514244
[TBL] [Abstract][Full Text] [Related]
11. [Differential cell growth inhibition and terminal differentiation induction by chemotherapeutic agents of a human acute myelogenous leukemia cell line (HL-60) in vitro].
Himori T; Ohnuma T; Wakui A
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1605-11. PubMed ID: 6591856
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor proteins as regulators of cell differentiation.
Li ZR; Hromchak R; Mudipalli A; Bloch A
Cancer Res; 1998 Oct; 58(19):4282-7. PubMed ID: 9766653
[TBL] [Abstract][Full Text] [Related]
13. Kinetic rationale for cytokine-induced recruitment of myeloblastic leukemia followed by cycle-specific chemotherapy in vitro.
Tafuri A; Andreeff M
Leukemia; 1990 Dec; 4(12):826-34. PubMed ID: 2243506
[TBL] [Abstract][Full Text] [Related]
14. A regulatory role for tumor necrosis factor (TNF) in ML-1 human myeloblastic leukemia cell maturation.
Fujii Y; Takuma T; Bloch A
Leuk Res; 1990; 14(11-12):941-7. PubMed ID: 2280608
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor alpha down-regulates c-myc mRNA expression and induces in vitro monocytic differentiation in fresh blast cells from patients with acute myeloblastic leukemia.
Bergamaschi G; Carlo-Stella C; Cazzola M; De Fazio P; Pedrazzoli P; Peverali FA; Della Valle G
Leukemia; 1990 Jun; 4(6):426-30. PubMed ID: 2359342
[TBL] [Abstract][Full Text] [Related]
16. Differentiation-inducing effect of recombinant human tumor necrosis factor alpha and gamma-interferon in vitro on blast cells from patients with acute myeloid leukemia and myeloid blast crisis of chronic myeloid leukemia.
Geissler K; Tricot G; Leemhuis T; Walker E; Broxmeyer HE
Cancer Res; 1989 Jun; 49(11):3057-62. PubMed ID: 2497971
[TBL] [Abstract][Full Text] [Related]
17. Regulation by retinoic acid and hydrocortisone of the anthracycline sensitivity of blast cells of acute myeloblastic leukemia.
Yang GS; Minden MD; McCulloch EA
Leukemia; 1994 Dec; 8(12):2065-75. PubMed ID: 7807996
[TBL] [Abstract][Full Text] [Related]
18. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
Niitsu N; Ishii Y; Matsuda A; Honma Y
Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
[TBL] [Abstract][Full Text] [Related]
19. Post-transcriptional regulation of bcl-2 in acute myeloblastic leukemia: significance for response to chemotherapy.
Hu ZB; Minden MD; McCulloch EA
Leukemia; 1996 Mar; 10(3):410-6. PubMed ID: 8642855
[TBL] [Abstract][Full Text] [Related]
20. Effect of 5637-conditioned medium and recombinant cytokines on P-glycoprotein expression in a human GM-CSF-dependent leukemic myeloid cell line.
Bailly JD; Pourquier P; Jaffrézou JP; Duchayne E; Cassar G; Bordier C; Laurent G
Leukemia; 1995 Oct; 9(10):1718-25. PubMed ID: 7564516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
